Wikoryl ND 4 mg/60 mg Tablet may cause excessive drowsiness with alcohol.
Information regarding the use of Wikoryl ND 4 mg/60 mg Tablet during pregnancy is not available. Please consult your doctor.
Wikoryl ND 4 mg/60 mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Wikoryl ND 4 mg/60 mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Wikoryl ND 4 mg/60 mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Wikoryl ND 4 mg/60 mg Tablet may not be needed in these patients. Please consult your doctor. Use of Wikoryl ND 4 mg/60 mg Tablet may cause excessive sleepiness in patients with end stage kidney disease.
Wikoryl ND 4 mg/60 mg Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Wikoryl ND 4 mg/60 mg Tablet may be needed. Please consult your doctor.
If you miss a dose of Wikoryl ND 4 mg/60 mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More